193 related articles for article (PubMed ID: 27167190)
1. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract][Full Text] [Related]
2. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
[TBL] [Abstract][Full Text] [Related]
3. miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
Yang Y; Song S; Meng Q; Wang L; Li X; Xie S; Chen Y; Jiang X; Wang C; Lu Y; Xin X; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
J Cell Mol Med; 2020 Mar; 24(5):2772-2790. PubMed ID: 32030886
[TBL] [Abstract][Full Text] [Related]
4. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.
Yang Y; Meng Q; Wang C; Li X; Lu Y; Xin X; Zheng Q; Lu D
J Mol Med (Berl); 2018 Oct; 96(10):1119-1130. PubMed ID: 30140938
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation.
Gui X; Li H; Li T; Pu H; Lu D
Mol Ther; 2015 Dec; 23(12):1843-53. PubMed ID: 26347501
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory factor receptor Toll-like receptor 4 controls telomeres through heterochromatin protein 1 isoforms in liver cancer stem cell.
Zheng Q; Xu J; Lin Z; Lu Y; Xin X; Li X; Yang Y; Meng Q; Wang C; Xiong W; Lu D
J Cell Mol Med; 2018 Jun; 22(6):3246-3258. PubMed ID: 29602239
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
Dando I; Cordani M; Donadelli M
IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
[TBL] [Abstract][Full Text] [Related]
10. RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.
Li T; Zheng Q; An J; Wu M; Li H; Gui X; Pu H; Lu D
Mol Ther; 2016 Feb; 24(2):261-275. PubMed ID: 26581161
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling.
Zheng Q; Lin Z; Li X; Xin X; Wu M; An J; Gui X; Li T; Pu H; Li H; Lu D
Sci Rep; 2016 Nov; 6():36843. PubMed ID: 27833137
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.
An J; Wu M; Xin X; Lin Z; Li X; Zheng Q; Gui X; Li T; Pu H; Li H; Lu D
Oncotarget; 2016 Aug; 7(31):50131-50149. PubMed ID: 27367027
[TBL] [Abstract][Full Text] [Related]
14. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.
Yang W; Xia Y; Hawke D; Li X; Liang J; Xing D; Aldape K; Hunter T; Alfred Yung WK; Lu Z
Cell; 2012 Aug; 150(4):685-96. PubMed ID: 22901803
[TBL] [Abstract][Full Text] [Related]
15. Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein.
Warnock LJ; Knox A; Mee TR; Raines SA; Milner J
Cancer Biol Ther; 2008 Sep; 7(9):1481-9. PubMed ID: 18769132
[TBL] [Abstract][Full Text] [Related]
16. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MEG3 blocks telomerase activity in human liver cancer stem cells epigenetically.
Jiang X; Wang L; Xie S; Chen Y; Song S; Lu Y; Lu D
Stem Cell Res Ther; 2020 Nov; 11(1):518. PubMed ID: 33256840
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
[TBL] [Abstract][Full Text] [Related]
19. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
20. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]